Results 31 to 40 of about 105,783 (286)

The use of non-selective beta-blockers in patients with cirrhosis: more doubts than certainties [PDF]

open access: yes, 2017
In conclusion, prospective RCT would be needed on the use of NSBBs in decompensated cirrhotic patients with ascites however these trials are difficult to organize and will need a large sample size.
Di Gregorio, Vincenza   +3 more
core   +1 more source

Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation

open access: yesThe Turkish Journal of Gastroenterology, 2020
Background/Aims: An increased post-operative mortality risk has been reported among patients who undergo living donor liver transplantation (LDLT) with higher model for end-stage liver disease (MELD) scores.
Şencan Acar   +4 more
doaj   +1 more source

MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis

open access: yesMedicina, 2023
Background and Objectives: The Child–Pugh (CP) score and Model for End-Stage Liver Disease (MELD) are classical systems for predicting mortality in patients with liver cirrhosis (LC).
Jung-Woo Kim   +4 more
doaj   +1 more source

Blind protein structure prediction using accelerated free-energy simulations. [PDF]

open access: yes, 2016
We report a key proof of principle of a new acceleration method [Modeling Employing Limited Data (MELD)] for predicting protein structures by molecular dynamics simulation.
Brini, Emiliano   +4 more
core   +1 more source

SURGICAL RISK ASSESSMENT IN PATIENTS WITH LIVER CIRRHOSIS – A LITERATURE REVIEW [PDF]

open access: yesJournal of IMAB
Patients with chronic liver injury and liver cirrhosis develop disease-specific pathophysiological abnormalities. These specific findings compromise the functional activity of other organs and systems, leading to poor postoperative outcomes and increased
Elina Merashka
doaj   +1 more source

Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. [PDF]

open access: yesPLoS ONE, 2013
Allocation of donor livers for transplantation in most regions is based on the Model for End-Stage Liver Disease (MELD) or MELD-sodium (MELDNa). Our objective was to assess revisions to MELD and MELDNa that include serum albumin for predicting waiting ...
Robert P Myers   +4 more
doaj   +1 more source

MELD–Na as a prognostic score for cirrhotic patients

open access: yesJournal de la Faculté de Médecine d'Oran, 2023
Background-The high mortality of cirrhosis is a global public health problem. For predicting the outcome of patients with cirrhosis, many prognostic models were proposed.The new Model for End-Stage Liver Disease including serum sodium (MELD-Na) has been ...
Yousra Meguenni   +5 more
doaj  

The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score [PDF]

open access: yes, 2014
Prognosis for patients with cirrhosis admitted to intensive care unit (ICU) is poor. ICU prognostic models are more accurate than liver-specific models.
Agarwal, B   +6 more
core   +1 more source

Clostridioides difficile Infection and Liver Cirrhosis – A Retrospective, Cohort Study

open access: yesClinical and Experimental Gastroenterology, 2021
Nikhitha Mantri,1 Harish Patel,1,2 Kanthi Rekha Badipatla,1,2 Haozhe Sun,1 Danial Shaikh,1,2 Sudharsan Gongati,1 Suresh Kumar Nayudu1,2 1Department of Medicine, Bronx Care Health System, Affiliated with Icahn School of Medicine at Mount Sinai, Bronx, NY,
Mantri N   +6 more
doaj  

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study [PDF]

open access: yes, 2012
Background: Interleukin-22 (IL-22), recently identified as a crucial parameter of pathology in experimental liver damage, may determine survival in clinical end-stage liver disease.
Bachmann, Malte   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy